← Back to home
Comparison · Analytics

Grafana Mimir vs serofoi

A side-by-side editorial comparison of Grafana Mimir and serofoi — release velocity, themes, recent moves, and the top alternatives to consider.

Grafana Mimir vs serofoi: at a glance

FeatureGrafana Mimirserofoi
SectorAnalyticsAnalytics
Velocity score5.00.0
Sparks · 30d00
Top themesmetrics, prometheus-compatible, helm, packagingepiverse-trace, serology, force-of-infection, bayesian-inference
Last editorial update17h ago4d ago
WebsiteVisit →Visit →

What is Grafana Mimir?

Mimir's feed is a weekly Helm bot, with the 3.2 candidate the only real release in months

The visible cadence is an automated weekly Helm chart release opened by a bot with a two-line body, now at 6.3.0-weekly.408. The only substantive entry in the window is the 3.2.0 release candidate from early August, which carried query engine work and native histogram support.

Read the full Grafana Mimir trajectory →

What is serofoi?

serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.

serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.

Read the full serofoi trajectory →

Grafana Mimir vs serofoi: editorial side-by-side

G
Grafana Mimir
ANALYTICS
5.0

Mimir's feed is a weekly Helm bot, with the 3.2 candidate the only real release in months

◆ Current state

The visible cadence is an automated weekly Helm chart release opened by a bot with a two-line body, now at 6.3.0-weekly.408. The only substantive entry in the window is the 3.2.0 release candidate from early August, which carried query engine work and native histogram support.

◆ Where it's heading

Packaging and the engine move on separate clocks: the chart ships weekly regardless of whether anything changed underneath, while Mimir itself cuts a minor roughly monthly. The weekly stream tells you nothing about direction and will keep dominating the feed by volume.

◆ Prediction

The chart line moving from 6.2.0-weekly to 6.3.0-weekly points at a 6.3.0 chart release carrying Mimir 3.2 once the candidate goes final.

S
serofoi
ANALYTICS
0.0

serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.

◆ Current state

serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.

◆ Where it's heading

The package moved from fitting-only to a fit-and-simulate pair. 0.1.0 added simulation from time- or age-varying force-of-infection trends and simplified the fitted object down to a Stan fit; 1.0.2 broadened simulation into full serosurvey generation with its own vignette. 1.0.3 then spent its effort on naming consistency and plotting options, which is what a package does once its scope is set.

◆ Prediction

With simulation and fitting both in place, the natural next step is tooling that closes the loop between them — recovery checks or study-design guidance built on simulated surveys.

Alternatives to Grafana Mimir and serofoi

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either Grafana Mimir or serofoi.

See all Grafana Mimir alternatives → · See all serofoi alternatives →

Recent activity from Grafana Mimir and serofoi

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1d agoGrafana MimirAutomated weekly Helm chart release 6.3.0-weekly.408
  2. 8d agoGrafana Mimirmimir-distributed-6.2.0-weekly.407: Release mimir-distributed Helm chart 6.2.0-weekly.407 (#16334)
  3. 15d agoGrafana Mimirmimir-distributed-6.2.0-weekly.406: Release mimir-distributed Helm chart 6.2.0-weekly.406 (#16287)
  4. 15d agoGrafana MimirMimir 3.2 RC: query engine work and native histogram support
  5. 1mo agoGrafana Mimirmimir-distributed-6.2.0-weekly.402: Release mimir-distributed Helm chart 6.2.0-weekly.402 (#15973)
  6. 1mo agoGrafana Mimirmimir-distributed-6.2.0-weekly.401: Release mimir-distributed Helm chart 6.2.0-weekly.401 (#15877)
  7. 1y agoserofoiConstant FoI plots, r-hat plotting and shorter parameter names
  8. 1y agoserofoiSerological surveys can now be simulated end to end
  9. 2y agoserofoiSimulation functions added; fitted output simplified to a Stan fit
  10. 3y agoserofoiFirst release: three force-of-infection models and the core modules

Frequently asked questions

What is the difference between Grafana Mimir and serofoi?

They serve adjacent needs but don't currently overlap on shipped themes. Grafana Mimir is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is Grafana Mimir better than serofoi?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Grafana Mimir is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to Grafana Mimir?

Top Grafana Mimir alternatives in Analytics are ranked by recent ship velocity. Browse the "Grafana Mimir alternatives" section above for the current picks, or visit /alternatives/grafana-mimir for the full list with editorial commentary on each.

What are the best alternatives to serofoi?

Top serofoi alternatives in Analytics are ranked by recent ship velocity. Browse the "serofoi alternatives" section above for the current picks, or visit /alternatives/serofoi for the full list with editorial commentary on each.